-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gsj7YB68gubVH8ZKxBl8DN2upBT0A+dHaQX+IXx5CgfGFE2dGe09+9jnumlTmSHC Y6wmkoVqlAcvhD3wihgvqQ== 0000950123-01-509245.txt : 20020413 0000950123-01-509245.hdr.sgml : 20020413 ACCESSION NUMBER: 0000950123-01-509245 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20011213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-02516 FILM NUMBER: 1813057 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 15-12B 1 y55743e15-12b.txt PHARMACIA CORPORATION SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(B) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 1-2516 PHARMACIA CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) 100 ROUTE 206 NORTH PEAPACK, NEW JERSEY 07977 (908) 901-8000 (ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES) 6.50% ADJUSTABLE CONVERSION-RATE EQUITY SECURITY UNITS (TITLE OF EACH CLASS OF SECURITIES COVER BY THIS FORM) COMMON STOCK, PAR VALUE $2.00 PER SHARE RIGHTS TO PURCHASE PREFERRED STOCK (TITLES OF ALL OTHER CLASSES OF SECURITIES FOR WHICH A DUTY TO FILE REPORTS UNDER SECTION 13(A) OR 15(D) REMAINS) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g - 4(a)(1)(i) [X] Rule 12h - 3(b)(1)(ii) [ ] Rule 12g - 4(a)(1)(ii) [ ] Rule 12h - 3(b)(2)(i) [ ] Rule 12g - 4(a)(2)(i) [ ] Rule 12h - 3(b)(2)(ii) [ ] Rule 12g - 4(a)(2)(ii) [ ] Rule 15d - 6 [ ] Rule 12h - 3(b)(1)(i) [X]
Approximate number of holders of record as of the certification or notice date: None SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, Pharmacia Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. PHARMACIA CORPORATION Date: December 13, 2001 By: /s/ DON W. SCHMITZ -------------------------------------- Name: Don W. Schmitz Title: Vice President, Associate General Counsel and Corporate Secretary
-----END PRIVACY-ENHANCED MESSAGE-----